By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Samsung spinoff wins FDA clearance for AI ECG analysis software
    By
    msadmin
    October 11, 2026
    A robotics upstart banks $75M to build drugs without hands
    By
    msadmin
    October 11, 2026
    Isomorphic Labs weighs a $40B price tag before its first trial
    By
    msadmin
    October 11, 2026
    FDA clears software that builds 3D bone from a routine spine MRI
    By
    msadmin
    October 11, 2026
    Vitalize raises $31M to run hospitals like air traffic control
    By
    msadmin
    October 11, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & AlertsSpotlight

Sage Healthspan Launches AI-Powered Precision Health App With Privacy-First Design

The free iOS app uses on-device AI to interpret lab results, detect health trends, and offer personalized wellness guidance—all without compromising data privacy.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: June 27, 2025
Share
4 Min Read
SHARE

As first reported by GlobeNewswire, California-based digital health company Sage Healthspan has unveiled its new precision health app on Apple’s App Store, offering users the ability to privately analyze and act on their blood work using artificial intelligence. The app addresses a critical gap in preventive healthcare—helping individuals make sense of routine lab results that often go underexplained unless serious abnormalities are found. By turning raw data into clear insights, Sage aims to shift users from reactive to proactive healthcare engagement.

Contents
Intelligent insights without compromising privacyMeeting the need for patient-centered digital tools

Source: apps.apple.com/us/app/sage-healthspan.

“Instead of waiting for symptoms to appear, Sage empowers users to engage proactively with their health data,” said Megan Haas, Media and Communications Lead at Sage Healthspan. Users can upload or photograph lab results, which the app then analyzes locally using secure, HIPAA-compliant AI models. This privacy-centric approach ensures that sensitive data never leaves the user’s device, providing both actionable insights and peace of mind.

Intelligent insights without compromising privacy

Sage’s AI engine spans a broad range of health indicators—cardiometabolic health, inflammation, blood sugar, hormone levels, nutrient status, kidney and liver function, and more. Over time, the platform builds a personalized health timeline, detecting trends and suggesting interventions such as lifestyle changes, supplements, or additional tests. Unlike traditional apps that rely on cloud storage, Sage keeps all data processing on the user’s device, a critical distinction in an era where cybersecurity concerns are paramount.

Additionally, the app allows users to independently order advanced biomarker tests not typically included in standard panels. These range from cardiovascular indicators like ApoB and Lp(a) to metabolic markers such as fasting insulin and nutritional metrics like vitamin D and omega-3 levels. This self-directed capability encourages users to explore deeper levels of their health beyond the constraints of a standard clinical visit.

Meeting the need for patient-centered digital tools

With primary care appointments often limited to under 20 minutes, many patients struggle to fully understand their lab results or address broader wellness questions. According to recent research, 67% of patients feel confused by their lab data. Sage Healthspan offers a solution by translating complex medical terms into user-friendly insights, serving as a complementary tool to traditional healthcare while advancing the goals of early detection and personalized care.

The company’s launch also signals alignment with the broader shift toward “Medicine 3.0”—a model of care that emphasizes prevention, personalization, and patient empowerment. With chronic conditions accounting for nearly 90% of U.S. healthcare costs, tools like Sage that promote early intervention and data-driven decisions could play a pivotal role in reshaping care delivery.

Sage Healthspan’s new AI-powered app combines convenience, precision, and privacy to transform how individuals engage with their health data. By leveraging on-device intelligence and a robust set of biomarker insights, the app marks a significant step toward democratizing preventive care—empowering users to take charge of their wellness journey without sacrificing data security.

VIA:GlobeNewswire
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

News & Alerts

CHAI builds playbooks for frontier AI cyber threats in health

By
msadmin
August 13, 2026
ArticlesNews & Alerts

Google’s TabFM Makes Accurate Predictions Without Fine-Tuning Per Dataset

By
msadmin
July 12, 2026
News & Alerts

Frontier AI models beat specialized clinical tools in new benchmark

By
msadmin
July 18, 2026
News & Alerts

Oura carries 42 billion hours of health data into its IPO

By
msadmin
September 6, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal